Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.
about
Daclizumab high-yield process in the treatment of relapsing-remitting multiple sclerosisPregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity.Daclizumab: A Review in Relapsing Multiple Sclerosis.Daclizumab for the treatment of relapsing-remitting multiple sclerosis.Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis.Population PK-PD analyses of CD25 occupancy, CD56bright NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis.The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.Daclizumab.
P2860
Q33589947-58DCF52E-5019-4A16-BFDF-0951AC659F4EQ37459065-0BC2662C-8CA4-4C9E-BEAA-2844E5A96080Q38962519-460C4DFE-8C87-4C41-A689-4D4758D7DE9EQ39140303-DF20DDE6-16A5-4D14-97C9-FB05A0629F78Q39175716-939B994B-B876-4E20-86EB-913A7750FE69Q39434495-426FA73E-8EE6-4775-8E04-8EFE79293518Q42700892-0CB786FA-20C4-4EA4-825B-C3CE921FD90FQ45066717-B08FDCE0-76C1-4F4C-B023-0459BBD738E1Q46487963-FB575B62-D0CF-44EF-8262-7A8B6D491923
P2860
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Population Pharmacokinetics of ...... f Phase I-III Clinical Trials.
@en
type
label
Population Pharmacokinetics of ...... f Phase I-III Clinical Trials.
@en
prefLabel
Population Pharmacokinetics of ...... f Phase I-III Clinical Trials.
@en
P2093
P2860
P1476
Population Pharmacokinetics of ...... of Phase I-III Clinical Trials
@en
P2093
Ivan Nestorov
Jonathan Q Tran
Yaming Hang
P2860
P2888
P304
P356
10.1007/S40262-016-0366-7
P577
2016-08-01T00:00:00Z
P6179
1036158371